Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People with a specific type of ovarian, fallopian tube, or primary peritoneal cancer that is high-grade serous, has stopped responding to platinum-based chemotherapy, and has tested positive for a protein called folate receptor-alpha (meaning at least 75% of cancer cells show this protein at a moderate-to-strong level) — and who have already received between one and three prior cancer treatment courses, as outlined in the approved product guidelines.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom the drug mirvetuximab soravtansine-gynx (MIRV) is not medically appropriate based on its approved prescribing guidelines.
- People who are currently taking part in another clinical trial involving an investigational (not yet fully approved) drug.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Number of Participants With Adverse Events (AE)s
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.